Editorial
doi: 10.1148/radiol.2018181717.
Epub 2018 Sep 4.
Diffusion-weighted MRI in Multicenter Trials of Breast Cancer: A Useful Measure of Tumor Response?
Affiliations
- PMID: 30179102
- DOI: 10.1148/radiol.2018181717
Item in Clipboard
Editorial
Diffusion-weighted MRI in Multicenter Trials of Breast Cancer: A Useful Measure of Tumor Response?
Radiology.
2018 Dec.
No abstract available
Comment in
-
Diffusion-weighted MRI in Multicenter Trials of Breast Cancer.Radiology. 2019 May;291(2):546. doi: 10.1148/radiol.2019190446. Epub 2019 Apr 2. Radiology. 2019. PMID: 30938630 No abstract available.
Comment on
-
Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial.Radiology. 2018 Dec;289(3):618-627. doi: 10.1148/radiol.2018180273. Epub 2018 Sep 4. Radiology. 2018. PMID: 30179110 Free PMC article. Clinical Trial.
Similar articles
-
Diffusion-weighted MRI in Multicenter Trials of Breast Cancer.Radiology. 2019 May;291(2):546. doi: 10.1148/radiol.2019190446. Epub 2019 Apr 2. Radiology. 2019. PMID: 30938630 No abstract available.
-
Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer using diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging.Neoplasma. 2017;64(3):430-436. doi: 10.4149/neo_2017_314. Neoplasma. 2017. PMID: 28253722
-
Feasibility of 7 Tesla breast magnetic resonance imaging determination of intrinsic sensitivity and high-resolution magnetic resonance imaging, diffusion-weighted imaging, and (1)H-magnetic resonance spectroscopy of breast cancer patients receiving neoadjuvant therapy.Invest Radiol. 2011 Jun;46(6):370-6. doi: 10.1097/RLI.0b013e31820df706. Invest Radiol. 2011. PMID: 21317792 Clinical Trial.
-
Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer?Breast Cancer Res Treat. 2012 Aug;135(1):17-28. doi: 10.1007/s10549-012-2033-5. Epub 2012 Apr 4. Breast Cancer Res Treat. 2012. PMID: 22476850 Review.
-
Role of breast MR imaging in neoadjuvant chemotherapy.Magn Reson Imaging Clin N Am. 2010 May;18(2):249-58, viii-ix. doi: 10.1016/j.mric.2010.02.008. Magn Reson Imaging Clin N Am. 2010. PMID: 20494310 Review.
Cited by
-
Preoperative Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Cancer Using 18F-FDG PET/CT and DW-MRI: A Prospective Multicenter Study.Int J Radiat Oncol Biol Phys. 2020 Apr 1;106(5):998-1009. doi: 10.1016/j.ijrobp.2019.12.038. Epub 2020 Jan 25. Int J Radiat Oncol Biol Phys. 2020. PMID: 31987972 Free PMC article. Clinical Trial.
-
Diffusion-weighted imaging of the breast: current status as an imaging biomarker and future role.BJR Open. 2019 Mar 8;1(1):20180049. doi: 10.1259/bjro.20180049. eCollection 2019. BJR Open. 2019. PMID: 33178933 Free PMC article. Review.
-
Prediction of PD-1 Expression and Outcomes of Combined Therapy in Hepatocellular Carcinoma: an MRI-Based Radiomics Approach.J Imaging Inform Med. 2025 May 12. doi: 10.1007/s10278-024-01381-7. Online ahead of print. J Imaging Inform Med. 2025. PMID: 40355688
-
Ensemble Learning for Breast Cancer Lesion Classification: A Pilot Validation Using Correlated Spectroscopic Imaging and Diffusion-Weighted Imaging.Metabolites. 2023 Jul 11;13(7):835. doi: 10.3390/metabo13070835. Metabolites. 2023. PMID: 37512542 Free PMC article.
-
Correlated MR spectroscopic imaging of breast cancer to investigate metabolites and lipids: acceleration and compressed sensing reconstruction.BJR Open. 2022 Oct 12;4(1):20220009. doi: 10.1259/bjro.20220009. eCollection 2022. BJR Open. 2022. PMID: 36860693 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
